Eterna Therapeutics Inc
ERNA2.290USD
-0.080-3.38%
종가 06/13, 16:00（ET）시세는 15분 지연됩니다
119.65M시가총액
손실P/E TTM
자세한 내용은 Ernexa Therapeutics Inc 회사
Ernexa Therapeutics Inc., formerly Eterna Therapeutics Inc., is a preclinical-stage company. The Company is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The Company seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The Company is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.
회사 정보
종목 코드 ERNA
회사 이름Ernexa Therapeutics Inc
상장일Aug 29, 1991
설립일1984
CEOMr. Sanjeev Luther
직원 수6
유형Ordinary Share
회계 연도 종료Aug 29
주소1035 Cambridge Street
도시CAMBRIDGE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호02141
전화16177986700
웹사이트https://www.ernexatx.com/
종목 코드 ERNA
상장일Aug 29, 1991
설립일1984
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. James Bristol
Dr. James Bristol
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sanjeev Luther
Mr. Sanjeev Luther
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Sandra Gurrola
Ms. Sandra Gurrola
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Mr. Peter Cicala
Mr. Peter Cicala
Independent Director
Independent Director
--
--
Dr. Elena Ratner
Dr. Elena Ratner
Independent Director
Independent Director
--
--
Mr. William Wexler
Mr. William Wexler
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. James Bristol
Dr. James Bristol
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sanjeev Luther
Mr. Sanjeev Luther
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Sandra Gurrola
Ms. Sandra Gurrola
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Mr. Peter Cicala
Mr. Peter Cicala
Independent Director
Independent Director
--
--
Dr. Elena Ratner
Dr. Elena Ratner
Independent Director
Independent Director
--
--
Mr. William Wexler
Mr. William Wexler
Independent Director
Independent Director
--
--
수익 분석
통화: USD마지막 업데이트: Mon, Feb 24
통화: USD마지막 업데이트: Mon, Feb 24
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Subscription revenue
4.88M
84.17%
Other revenue
492.00K
8.48%
Hardware revenue
426.00K
7.34%
지역별USD
이름
수익
비율
United States
5.48M
94.48%
Canada
320.00K
5.52%
사업별
지역별
사업별USD
이름
수익
비율
Subscription revenue
4.88M
84.17%
Other revenue
492.00K
8.48%
Hardware revenue
426.00K
7.34%
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Cherington (Charles)
37.73%
Freebird Partners LP
5.63%
Halpern (John D)
5.30%
Denny George P Iii
4.52%
Regolith Capital Investments LP
3.03%
Other
43.79%
주주
주주
비율
Cherington (Charles)
37.73%
Freebird Partners LP
5.63%
Halpern (John D)
5.30%
Denny George P Iii
4.52%
Regolith Capital Investments LP
3.03%
Other
43.79%
주주 유형
주주
비율
Individual Investor
48.37%
Corporation
12.51%
Investment Advisor/Hedge Fund
0.55%
Investment Advisor
0.33%
Hedge Fund
0.27%
Research Firm
0.16%
Venture Capital
0.04%
Other
37.77%
기관 주식 보유
마지막 업데이트: Mon, Feb 24
마지막 업데이트: Mon, Feb 24
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
53
40.16M
76.00%
+9.20M
2024Q4
54
33.02M
64.27%
+30.12M
2024Q3
67
2.84M
52.46%
-257.40K
2024Q2
83
2.52M
46.53%
-624.19K
2024Q1
121
2.54M
46.88%
-584.16K
2023Q4
126
2.36M
43.79%
-543.57K
2023Q3
142
2.77M
52.76%
-391.46K
2023Q2
146
2.77M
53.56%
-376.86K
2023Q1
150
2.98M
67.03%
+101.08K
2022Q4
155
3.12M
108.12%
+1.48M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Cherington (Charles)
16.63M
31.84%
+5.08K
+0.03%
Mar 10, 2025
Freebird Partners LP
5.14M
8.26%
--
--
Mar 10, 2025
Halpern (John D)
5.14M
8.26%
--
--
Mar 10, 2025
Denny George P Iii
4.94M
7.95%
+4.48M
+979.96%
Mar 10, 2025
Regolith Capital Investments LP
2.48M
3.99%
+2.48M
--
Mar 10, 2025
IAF, LLC
2.68M
4.31%
--
--
Mar 10, 2025
Purchase Capital LLC
1.00M
1.61%
+1.00M
--
Dec 31, 2024
Singer (Nicholas Jason)
810.00K
1.3%
+810.00K
--
Dec 31, 2024
Geode Capital Management, L.L.C.
257.31K
0.41%
+236.88K
+1.16K%
Dec 31, 2024
Corient Private Wealth LLC
262.86K
0.42%
--
--
Dec 31, 2024
더 보기
관련 ETF
마지막 업데이트: Fri, Jun 6
마지막 업데이트: Fri, Jun 6
이름
비율
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
비율0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
날짜
유형
비율
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
